Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 24 Neoplasms 12 Colonic Neoplasms 12 Breast Neoplasms 12 Prostatic Neoplasms 9 Polycythemia Vera 9 Venous Thromboembolism 8 Multiple Myeloma 8 Recurrence 5 Rectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Thrombocythemia, Essential 4 Ovarian Neoplasms 4 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Myeloproliferative Disorders 4 Barrett Esophagus 4 Precancerous Conditions 3 Melanoma 3 Esophageal Neoplasms 3 Adenomatous Polyps 3 Adenoma 3 Tobacco Use Disorder 2 Thrombosis 2 Thromboembolism 2 Smoking Cessation 2 Sarcoma 2 Primary Myelofibrosis 2 Neoplastic Cells, Circulating 2 Neoplasms by Site 2

Interventions

Cisplatin 76 Radiotherapy 44 pembrolizumab 39 Cetuximab 38 Paclitaxel 34 Carboplatin 33 Docetaxel 30 Fluorouracil 25 Radiotherapy, Intensity-Modulated 22 Nivolumab 18 Drug Therapy 14 Radiation 12 Erlotinib Hydrochloride 9 cemiplimab 8 Magnetic Resonance Spectroscopy 8 130-nm albumin-bound paclitaxel 8 durvalumab 7 atezolizumab 7 Cyclophosphamide 7 Afatinib 7 Surgical Procedures, Operative 6 Panitumumab 6 Leucovorin 6 Chemoradiotherapy 6 fludarabine 5 aldesleukin 5 Radiosurgery 5 Oxaliplatin 5 Methotrexate 5 Gemcitabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Squamous Cell × Aspirin × Clear all

NCT01496521 2011-12-21

CREAT

Beijing Friendship Hospital

Phase 3 Unknown

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡